Read more on: Innovation & Research

Combination Cancer Therapy: When two Treatments are Better than One

Cancer rarely follows a linear path; there are times of progress and times that raise questions about patients' safety. Doctors have understood that just one type of treatment isn’t enough to keep the cancer from growing. Treatment approaches had to evolve as tumors adapted to the changes and survived despite being in the treatment environment. Integrating different therapies, such as chemotherapy with immunotherapy, keeps options alive for doctors to tackle cancer in various ways. This new approach isn’t about adding new treatments but rather using existing ones thoughtfully.

Understanding the combination cancer therapy

Cancer can be tackled with more intensity if combined approaches work together. Instead of relying on one single approach, doctors design a plan that includes two therapies  that complement each other. For instance, chemotherapy shrinks the tumor, while immunotherapy is a complementary approach that boosts the patient’s immune system to attack cancer more effectively. Each treatment acts differently but has a common goal: to destroy cancer. These combined approaches are designed carefully to reduce any harm or side effects to the surrounding issues. When used carefully, these combined therapies can eliminate side effects and maintain the overall quality of life for patients.

Why is a combination approach better than a single one?

Chemotherapy and immunotherapy may look like totally different approaches for fighting cancer. But together, they work in better coordination. Chemotherapy shrinks the cancer tumor by breaking down the cancer cells and exposing them. This makes it easier for the immune system to spot and attack these broken-down cancerous cells. This is where immunotherapy steps in and boosts the immune system to recognize and destroy these cancerous cells with greater intensity. This integrated approach can improve how the treatment functions altogether without overwhelming the patient.

Cancer’s response to the combined therapy approach

The following are a few types of cancers that give a positive response to a combined therapy approach:

  • Lung cancer: Chemo with immunotherapy has helped patients achieve better outcomes and has also improved long-term disease control.
  • Breast cancer: Combination therapy has improved the treatment response and has eliminated the progression.
  • Head and neck cancers: The integrated approaches have reduced cancer recurrence and improved quality of life.
  • Gastrointestinal cancers: Combination therapy is becoming more effective than single treatments in the case of colorectal and gastric cancers.

Benefits and potential risks patients need to understand

BenefitsPotential side effects
Improved treatment responseIncreased fatigue and weakness
Longer disease controlNausea and appetite loss
Better effectiveness when one treatment isn’t enoughHigher risk of infections
Active immune system Immune-related reaction on the skin, gut, or thyroid
More treatment options for aggressive cancersNeeds closer monitoring 

For whom is combination therapy best suited?

The following are factors doctors consider before planning a combination therapy:

  • Cancer types and stages: This is the preliminary step to know what type and stage of cancer a patient is diagnosed with.
  • Overall health: Doctors assess the overall health of the patients to get an idea about their current state.
  • Biomarkers: Biomarkers help doctors predict the cancer tumor and what will work.
  • Previous treatments: Past treatment analysis helps doctors know what works for the patient.

A more coordinated future in cancer care

Combination therapy is a smarter step towards a more personalized cancer treatment. These therapies are growing with time and helping doctors tailor a balanced treatment that maintains patients' quality of life.